Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
Company leadership is framing the move as transformational.
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
The company has achieved a turnover of around Rs 100 crore in FY 2025–26 and aims to achieve a turnover of Rs 500 crore in next three years
Subscribe To Our Newsletter & Stay Updated
